Jeffrey S Farrow Global Blood Therapeutics, Inc. (GBT) insider trading activity

Jeffrey S Farrow is Chief Financial Officer of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 26,739 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Jeffrey S Farrow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 05 2022	SELL Sale (or disposition) back to the issuer	-	26,739 Reduced 100.0%	0 Common Stock
Sep 27 2022	BUY Exercise of conversion of derivative security	$387,909 $16.4 p/Share	23,653 Added 46.94%	26,739 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$128,463 $68.15 p/Share	1,885 Reduced 5.18%	34,527 Common Stock
Sep 01 2022	SELL Open market or private sale	$2,137,988 $68.0 p/Share	31,441 Reduced 91.06%	3,086 Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	4,971 Added 12.01%	36,412 Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$68,882 $32.4 p/Share	2,126 Reduced 6.33%	31,441 Common Stock
Aug 01 2022	BUY Exercise of conversion of derivative security	-	6,145 Added 15.47%	33,567 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$39,279 $29.87 p/Share	1,315 Reduced 4.58%	27,422 Common Stock
Mar 01 2022	BUY Exercise of conversion of derivative security	-	2,763 Added 8.77%	28,737 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$132,161 $29.33 p/Share	4,506 Reduced 14.78%	25,974 Common Stock
Feb 01 2022	BUY Exercise of conversion of derivative security	-	9,020 Added 22.84%	30,480 Common Stock
Sep 01 2021	SELL Payment of exercise price or tax liability	$40,895 $29.85 p/Share	1,370 Reduced 6.0%	21,460 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	-	2,762 Added 10.79%	22,830 Common Stock
Aug 01 2021	SELL Payment of exercise price or tax liability	$118,995 $27.33 p/Share	4,354 Reduced 17.83%	20,068 Common Stock
Aug 01 2021	BUY Exercise of conversion of derivative security	-	9,020 Added 26.97%	24,422 Common Stock
Feb 01 2021	SELL Payment of exercise price or tax liability	$290,259 $49.49 p/Share	5,865 Reduced 27.58%	15,402 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	-	12,083 Added 36.23%	21,267 Common Stock

Also insider at

TARS

Tarsus Pharmaceuticals, Inc. Healthcare

Officer

JSF

Jeffrey S Farrow

Chief Financial Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Value

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Global Blood Therapeutics, Inc.

Track Activities on GBT

Account